Type 1 diabetes patients with defective glucagon and adrenaline response to hypoglycaemia have a 25-fold or greater increased risk of iatrogenic hypoglycaemia during intensive insulin therapy [54]. The gene discussed is GCG; the disease is Hypoglycemia.